Data and WebsitesPrince, you said you want more data. The Morales-published article on P3 has enough data to choke a horse. The previous Morales-published article on P2 has less data than P3 but is still substantial. I regarded the old BNC website as largely uninformative. I'm puzzled why you thought it was good. TST doesn't need more retail investors. They need fund managers to come back. So if you sell your compete holding, we would understand but we wouldn't be concerned. You don't have to keep repeating the "skinny data" thing. This has never been a secret. Per the FDA/AUA sumposium in Philadelphi, the key thing about clinical trial size is statistical significance. It's just science and math.